Elevated neutrophil-to-lymphocyte ratio as a prognostic factor in primary central nervous system lymphoma [0.03%]
中性粒细胞与淋巴细胞比值升高是原发中枢神经系统淋巴瘤的预后因素
Ruba Memon,Ruju Talati,Richard Song et al.
Ruba Memon et al.
Background. Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that represents 4%-7% of all brain tumors. Several bodies of literature show that preoperative hematological values correlate with the progno...
Erica Gillespie,Elise Bouchal,Gordon Li et al.
Erica Gillespie et al.
In this manuscript, we discuss the use of neuromodulatory techniques such as intrathecal therapy (IT) and spinal cord stimulation (SCS) for cancer pain in neuro-oncology patients. Currently, cancer pain management relies on oral opioids, wh...
Omar Ashraf,Stacey Q Wolfe,Samuel Emerson et al.
Omar Ashraf et al.
Skull base meningiomas are challenging tumors to resect and confer a high risk of surgical morbidity due to their location in deep-seated regions of the cranium. These tumors can have robust and variable blood supply from branches of the in...
Neurosurgical oncology at the crossroads of neurosurgery subspecialties: Intersections of sections [0.03%]
神经外科各个亚专科的交叉口：神经外科肿瘤的位置
Isabelle M Germano,Gelareh Zadeh
Isabelle M Germano
Neurosurgical oncology is a rapidly advancing field, driven by interdisciplinary collaboration, technological innovation, and a growing understanding of tumor biology. As we celebrate the 40th anniversary of the AANS/CNS Section on Tumors, ...
Women in neurosurgical oncology: Mapping the milestones and shaping the future [0.03%]
神经外科肿瘤学中的女性：里程碑和塑造未来
Grace E Hey,Chloe L DeYoung,Kathleen S Botterbush et al.
Grace E Hey et al.
Neurosurgical oncology, which specifically focuses on the treatment of central nervous system tumors, emerged in 1879 after Dr. William Macewen successfully completed the first brain tumor resection. The field has since dramatically evolved...
Annee Nguyen,Trupti Trivedi,Ellen O&#x;Callaghan et al.
Annee Nguyen et al.
Vertebral metastatic disease results from many types of cancer and can have a devastating impact on patient mobility, psychological health, quality of life, and ultimately overall patient survival. However, the development of radiotherapy a...
The changing spectrum of neurointensive care unit needs for tumor patients [0.03%]
肿瘤患者的神经重症监护病房需求变化分析
Miriam M Shao,Maria Bederson,Kevin M Shao et al.
Miriam M Shao et al.
The neurointensive care unit (neuroICU) is well equipped to provide a high level of care for brain tumor patients, but it must also adapt to the changing needs of these patients. The current neuroICU needs of brain tumor patients are the fa...
Leveraging neuroscience imaging and electrophysiological assessments to decode neuron-glioma interactions [0.03%]
利用神经科学研究影像和电生理评估来解码神经元-胶质瘤相互作用
Sanjeev Herr,Sena Oten,Joshua D Bernstock et al.
Sanjeev Herr et al.
Increasing evidence has identified a complex relationship between neurons and malignant glial cells, leading to the rapid expansion of the field of cancer neuroscience. Of particular interest is the demonstrated ability of gliomas to integr...
Anthony C Wang,Winson S Ho,Lissa C Baird
Anthony C Wang
Adolescents and young adults (AYAs), defined as individuals aged 15-39, represent a distinct and underrepresented population in glioma research and clinical care. Gliomas are the most common central nervous system (CNS) tumors in this popul...
Ki-67 and overall survival in patients with glioblastoma: A systematic prognostic review and meta-analysis [0.03%]
Ki-67和总生存期与胶质母细胞瘤患者的预后：系统回顾和meta分析
Ida Kaalhus Nordahl,Claes Johnstad,Ole Solheim et al.
Ida Kaalhus Nordahl et al.
Background: Ki-67 labeling index (LI) is widely used to quantify tumor proliferation in cancer. Although helpful in assessing proliferative activity across gliomas, its prognostic value in glioblastoma remains uncertain. ...